Examples include consideration of leflunomide to rescue defective AKT signaling in patients with TTC7A deficiency and refurbishing IL1 antagonists after learning that CGD involves defective autophagy with increased IL1β activity. The gene discussed is AKT1; the disease is chronic granulomatous disease.